trending Market Intelligence /marketintelligence/en/news-insights/trending/wlpjsu3tlywmlkmdhevfka2 content esgSubNav
In This List

Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Cutera's nonsurgical fat removal system gets US FDA clearance for expanded use

The U.S. Food and Drug Administration cleared Cutera Inc.'s nonsurgical body sculpting system truSculpt 3D for lipolysis, or the breakdown of fat.

The device previously has FDA clearance for the reduction of fat without surgery.

Brisbane, Calif.-based Cutera is a medical device company that designs, develops, manufactures, markets and services laser and other energy-based aesthetics systems worldwide.